On Monday, Pixelworks, Inc. (NASDAQ:PXLW)’s shares inclined 14.66% to $5.71.
Pixelworks, Inc. (PXLW) an innovative provider of video display processing technology enabling the highest quality viewing experience for displays of all sizes, recently declared financial results for the first quarter ended March 31, 2015.
For the first quarter of 2015, revenue was $14.4 million, contrast to $15.1 million in the prior quarter and $13.5 million in the first quarter of 2014. The year-over-year enhance in revenue was primarily driven by 35 percent growth in chip revenue, reflecting market share gains in the projector market.
On a GAAP basis, gross profit margin in the first quarter of 2015 was 48.4%, contrast to 50.0% in the fourth quarter of 2014 and 59.0% in the first quarter of 2014. First quarter 2015 GAAP operating expenses were $10.2 million, contrast to $10.2 million in the previous quarter and $10.4 million in the first quarter of 2014.
For the first quarter of 2015, the Company recorded a GAAP net loss of $3.4 million, or $0.14 per share, contrast to a GAAP net loss of $2.8 million, or $0.12 per share, in the fourth quarter of 2014 and GAAP net loss of $2.5 million, or $0.11 per share, in the first quarter of 2014.
Pixelworks, Inc. designs, develops, and markets video and pixel processing semiconductors, intellectual property cores, software, and custom ASIC solutions for digital video applications. Its products allow manufacturers and developers of digital display and projection devices to manufacture screens of various sizes that display the highest video quality with minimum power consumption.
Pilgrim’s Pride Corporation (NASDAQ:PPC)’s shares dropped -2.60% to $24.92.
Pilgrim’s Pride Corporation (PPC) declared the Mexican Federal Economic Competition Commission (the “Commission”) has cleared the projected acquisition of Tyson Foods, Inc’s (“Tyson”) Mexican operations. This satisfies the final regulatory approval required for closing by the Commission, and the Company will now work with Tyson to complete the deal as soon as possible.
Tyson de Mexico has an estimated annual revenue of $650 million and the acquisition was valued at $400 million. Following completion of the deal, the Company will continue to supply Tyson through a co-packaging arrangement.
Pilgrim’s Pride Corporation engages in the production, processing, marketing, and distribution of fresh, frozen, and value-added chicken products to retailers, distributors, and foodservice operators in the United States, Mexico, and Puerto Rico. It offers fresh chicken products comprising pre-marinated or non-marinated, and prepackaged refrigerated (nonfrozen) whole or cut-up chicken in various combinations of refrigerated whole chickens and chicken parts.
At the end of Monday’s trade, Actavis plc (NYSE:ACT)‘s shares surged 0.77% to $309.16.
Actavis plc (ACT) declared that it has accomplished its acquisition of Auden Mckenzie Holdings Limited, a dynamic and fast growing company focused on the development, licensing and marketing of niche generic medicines and proprietary brands in the UK. Actavis attained Auden Mckenzie for about £306 million in cash, plus a two-year royalty on a percentage of gross profits of one of Auden Mckenzie’s products.
The acquisition of Auden Mckenzie makes Actavis the number one supplier of generic pharmaceuticals in the UK and gives the Company the number three position in the supply of UK pharmaceuticals.
Actavis plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes generic, branded generic, branded, biosimilar, and over-the-counter (OTC) pharmaceutical products. It operates in three segments: North American Brands, North American Generics and International, and Anda Distribution. The North American Brands segment provides patented and off-patent trademarked pharmaceutical products primarily under the Dalvance, Bystolic, Canasa, Carafate, Daliresp, Fetzima, Linzess, Namenda, Namenda XR, Saphris, Teflaro, Viibryd, Actonel, Asacol HD, Atelvia, Delzicol, Doryx, Estrace Cream, Enablex, Lo Loestrin Fe, and Minastrin 24 Fe brands. The North American Generics and International segment develops, manufactures, and sells generic, branded generic, and OTC pharmaceutical products. The Anda Distribution segment distributes generic and brand pharmaceutical products primarily to independent pharmacies, pharmacy chains and buying groups, and physicians offices.
Seagate Technology PLC (NASDAQ:STX), ended its Monday’s trading session with -0.79% loss, and closed at $55.20.
Seagate Technology PLC (STX) declared that it has raised the size of its formerly declared offering of $400 million aggregate principal amount of senior notes due 2027 (the “Notes.”) to $700 million. The Notes were priced at 99.718% of the aggregate principal amount and will bear interest at a rate of 4.875% per annum. The Notes will be issued by Seagate HDD Cayman (“HDD Cayman”), an indirect wholly owned partner of Seagate Technology plc (“Seagate”), and guaranteed by Seagate.
Seagate estimates that the net proceeds from the offering will be about $692 million after deducting underwriting discounts and estimated offering expenses.
HDD Cayman intends to use the net proceeds from the offering of the Notes for general corporate purposes, which may comprise, but are not limited to, replenishing cash associated with the redemption of the outstanding 6.875% Senior Notes due 2020, capital expenditures and other investments in the business.
Seagate Technology Public Limited Company designs, manufactures, and sells electronic data storage products in the Asia Pacific, the Americas, and EMEA countries. The company provides hard disk drives, solid state hybrid drives, and solid state drives that are designed for enterprise servers and storage systems in mission critical and nearline applications; for client compute applications comprising desktop and mobile computing; and for client non-compute applications, such as digital video recorders, personal data backup systems, portable external storage systems, and digital media systems.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
